ID
28250
Description
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Keywords
Versions (2)
- 12/7/17 12/7/17 -
- 12/31/17 12/31/17 -
Copyright Holder
Prof. Dr. med. Georg Heß
Uploaded on
December 31, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Patient Status GOAL Trial B-cell Lymphoma NCT02499003
Patient Status GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Description
Patient status
Alias
- UMLS CUI-1
- C0449437
Description
If 'Patient alive':
Alias
- UMLS CUI-1
- C3846084
Description
Date of follow up
Data type
date
Alias
- UMLS CUI [1]
- C3694716
Description
Disease Progression
Data type
text
Alias
- UMLS CUI [1]
- C0242656
Description
Date of diagnosis Disease Progression
Data type
date
Alias
- UMLS CUI [1,1]
- C2316983
- UMLS CUI [1,2]
- C0242656
Description
Method of Diagnosis
Data type
text
Alias
- UMLS CUI [1,1]
- C0332307
- UMLS CUI [1,2]
- C0449851
- UMLS CUI [1,3]
- C0011900
Description
other
Data type
text
Alias
- UMLS CUI [1]
- C0205394
Description
If 'Patient deceased':
Alias
- UMLS CUI-1
- C1555024
Similar models
Patient Status GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0242656 (UMLS CUI [1,2])
C0449851 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)